AOD-9604
≥99% HPLC verified · 2 sizes available
Modified C-terminal fragment of hGH studied in research on lipolytic and metabolic-pathway signaling.
Size
What research has shown
Synthetic compound
Defined synthetic material for controlled laboratory research and analytical method development.
In the literature
Cited across published research on peptide stability, receptor interaction, and biological signaling.
Lab settings
Examined in vitro and in preclinical models. Studies focus on molecular properties under controlled systems.
Non-therapeutic
For laboratory research only. Not approved for human consumption, treatment, or therapeutic application.
About this compound
AOD-9604 is a synthetic peptide derived from a modified C-terminal fragment of human growth hormone (specifically hGH 176-191). Structural modifications retain the lipolytic-signaling region of full-length hGH while removing the broader signaling activity associated with the complete molecule. The compound is referenced in research literature investigating lipolytic pathway signaling and metabolic substrate research models.
Each Perplexa lot is independently verified by HPLC and mass spectrometry. The lot-specific Certificate of Analysis is published on this product page before the lot ships.
This material is supplied for in vitro research only. It is not a drug, supplement, food, or cosmetic, and is not for human or veterinary consumption.
This material is supplied for in vitro research only. It is not a drug, supplement, food, or cosmetic, and is not for human or veterinary consumption.
Specifications
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC) |
| Size | 10mg |
| Vial | 3ml |
| Storage | -20°C, desiccated, protected from light |
| Origin | USA |
| Appearance | White lyophilized powder |
| Solubility | Soluble in bacteriostatic water, sterile saline |
| Mol. Weight | 1817.07 g/mol |
| Stability | 24 months at -20°C |
| Identity | Mass spectrometry |
Reconstitution, storage, and handling are the responsibility of the qualified researcher.Perplexa Labs does not provide protocols, dosing guidance, or human-use instructions.